United Therapeutics (UTHR) Tops Q1 EPS by 41c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $544.33 +1.12%
Revenue Growth %: +1.5%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +1.5%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $2.55, $0.41 better than the analyst estimate of $2.14. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $353.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Increasing unusual option volume: UTHR DOMO IHI XIFR ALKS AM CTSH GDS DFTX
- Worthington Enterprises raises dividend 5%, adds board member
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
